Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 3Recruiting 3Completed 3Terminated 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 44Squamous Cell Carcinoma of Head and Neck 22Head and Neck Neoplasms 21Rectal Neoplasms 17Colonic Neoplasms 15Neoplasm Metastasis 13Neoplasms 12Carcinoma, Squamous Cell 10Carcinoma, Non-Small-Cell Lung 10Recurrence 5Pancreatic Neoplasms 5Esophageal Neoplasms 4Mouth Neoplasms 3Lung Neoplasms 3Laryngeal Neoplasms 3Laryngeal Diseases 3Breast Neoplasms 3Tongue Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pharyngeal Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Squamous Cell 2Hereditary Sensory and Autonomic Neuropathies 2Glioma 2Glioblastoma 2Colorectal Cancer Metastatic 2Adenocarcinoma of Lung 2Adenocarcinoma Of Esophagus 2

Interventions

Capecitabine 3Fluorouracil 2Cetuximab 2Bevacizumab 2aflibercept 1Panitumumab 1Oxaliplatin 1Nivolumab 1Methotrexate 1Leucovorin 1Hypnosis 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Colorectal Cancer Metastatic × Cetuximab × Clear all
NCT06332079 2026-01-05

HAITI

Gruppo Oncologico del Nord-Ovest

Phase 2 Terminated
4 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT01522612 2016-06-10

Colorectal Cancer (CRC) Cetuximab Elderly Frail

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
5 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡